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Abstract
Lower organisms show promise for the screening of neurotoxicants that might target mammalian
brain development. Sea urchins use neurotransmitters as embryonic growth regulatory signals, so
that adverse effects on neural substrates for mammalian brain development can be studied in this
simple organism. We compared the effects of the organophosphate insecticide, chlorpyrifos in sea
urchin embryos with those of the monoamine depleter, reserpine, so as to investigate multiple
neurotransmitter mechanisms involved in developmental toxicity and to evaluate different
therapeutic interventions corresponding to each neurotransmitter system. Whereas reserpine
interfered with all stages of embryonic development, the effects of chlorpyrifos did not emerge until
the mid-blastula stage. After that point, the effects of the two agents were similar. Treatment with
membrane permeable analogs of the monoamine neurotransmitters, serotonin and dopamine,
prevented the adverse effects of either chlorpyrifos or reserpine, despite the fact that chlorpyrifos
works simultaneously through actions on acetylcholine, monoamines and other neurotransmitter
pathways. This suggests that different neurotransmitters, converging on the same downstream
signaling events, could work together or in parallel to offset the developmental disruption caused by
exposure to disparate agents. We tested this hypothesis by evaluating membrane permeable analogs
of acetylcholine and cannabinoids, both of which proved effective against chlorpyrifos- or reserpine-
induced teratogenesis. Invertebrate test systems can provide both a screening procedure for
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mammalian neuroteratogenesis and may uncover novel mechanisms underlying developmental
vulnerability as well as possible therapeutic approaches to prevent teratogenesis.
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INTRODUCTION
Although developmental neurotoxicity represents one of the major concerns for exposures to
environmental contaminants [26,32,75,76], fewer than 10% of all chemicals are ever screened
for neurotoxicity [41], whereas a much higher proportion will ultimately prove to be neurotoxic
either directly or through indirect mechanisms [9]. In recent years, attention has been focused
on pesticides in light of the ubiquitous exposure of human populations [78] but relatively few
compounds have actually been tested relative to the total number of pesticides in use [46,78].
Chlorpyrifos and other members of its class, the organophosphate insecticides, provide a
critical example of this problem. Because these agents elicit their systemic toxicity through
inhibition of acetylcholinesterase, it was originally thought that this mechanism provides a
predictive index for the outcomes of developmental exposures, whereas it is now apparent that
their ability to elicit developmental neurotoxicity involves multiple mechanisms, many of
which operate at doses below the threshold for cholinesterase inhibition [24,29,51,63–65].
These observations indicate that, in order to screen organophosphates for their developmental
neurotoxicity potential, developmental mechanisms and outcomes rather than surrogate
markers of exposure should be investigated [78]. In that regard, it is critically important that,
whereas the developing organism is resistant to the peripheral neuropathies typical of
organophosphate poisoning in the adult [33], the developing brain is far more vulnerable at
apparently subtoxic exposures [24,29,51,63–65]
Recent proposals for screening techniques focus on cell culture systems or lower organisms as
an initial step that would enable subsequent mammalian studies to concentrate on those
congeners with the highest potential for developmental neurotoxicity [28,64], an approach
endorsed in a report from the Inspector General of the EPA [78] as well as by outside groups
[27–29,64]. Because these techniques can focus on actual mechanisms involved in
developmental neurotoxicity, they are inherently more focused than a surrogate exposure
marker like cholinesterase activity. Indeed, we recently showed how neuronotypic PC12 cells
can serve to detect neurotoxicant actions at various stages of neural cell differentiation, with
screening capabilities extending to organophosphates, carbamates, organochlorines and heavy
metals [67]. Nevertheless, cell culture models share a critical limitation in that they focus on
direct neurotoxicant injury to neuronal cells and are problematic for assessment of cell-to-cell
interactions that play critical roles in brain assembly and are likely targets for disruption by
neurotoxicants. This is especially true for the organophosphates, which are toxic toward glial
cells that provide metabolic support for developing neurons and that guide axonal projections
to their appropriate targets during brain development [5,34–36,47,53,82,83]. Furthermore,
these agents also alter the release of a variety of neurotransmitters that have important trophic
functions during brain development, thus disrupting the differentiation and phenotypic fate of
their target cells [31,45,77,79].
Although these more complex mechanisms can be elucidated to some extent in whole embryos,
brain micromass cultures or mixtures of dissociated cells [47,57,82,83], approaches using
lower organisms are also suited for such purposes [16,19,23,44,50,58]. In a number of studies,
we evaluated the mechanisms involved in the adverse effects of organophosphates and a wide
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variety of related and unrelated environmental contaminants on mammalian brain development
using the sea urchin embryo [12,13,16–19,21–23,52,59]. Just as in the mammalian central
nervous system, the sea urchin embryo develops the ability to synthesize, store and release
neurotransmitters like acetylcholine, serotonin (5HT), dopamine and norepinephrine, and
possesses homologous populations of receptors and their downstream signaling cascades, with
appearance of all these components over a defined developmental period surrounding cell
differentiation and morphological assembly [17,37]. Accordingly, the neuroteratogens that
target specific neurotransmitter mechanisms or signaling cascades in the mammalian brain
have counterparts in “pre-nervous” morphogenetic anomalies in the developing sea urchin
[12,13,16–19,21–23,52,59]. The normal morphologic and biochemical features of sea urchin
development are well characterized and visible with routine light microscopy, and the
technique has been applied to developmental malformations evoked by a wide variety of
embryotoxins, teratogens and neurotoxicants [12,16,18–20,23,38,52]. Each sea urchin
produces numerous offspring that develop rapidly and with a specific sequence of
morphological events and the adverse effects of toxicants produce a uniform phenotype [18,
19,23,52].
In our previous work with chlorpyrifos and other organophosphates in the sea urchin model,
we focused on disruption of acetylcholine neurotransmitter systems as a target for underlying
mechanisms and adverse outcomes, as distinct from cholinesterase inhibition per se [15,19,
23,52]. However, organophosphates also disrupt the development of other neurotransmitter
systems that subserve trophic functions in the developing mammalian brain, notably 5HT and
dopamine [1–4,30,67,68,70,72]. In the current study, we examined the role of these systems
in the developmental outcomes evoked by chlorpyrifos exposure in three ways. First, we
compared the effects of chlorpyrifos to those of reserpine, a drug that depletes monoamines
by inhibiting the vesicular monoamine transporter [61] and as a consequence, disrupts
mammalian brain development linked to the trophic effects of monoamine transmitters [6,10,
42,49,74]. Second, we evaluated the ability of different analogs of these neurotransmitters to
offset the effects of chlorpyrifos and compared the results to their ability to prevent the adverse
effects of reserpine. The analogs all possess arachidonoyl moieties to facilitate lipid solubility
as required to penetrate into the embryo, and the biological activities of these agents have been
verified in extensive earlier work [7,14,15,18,19]. Finally, we evaluated a broader spectrum
of analogs aimed at additional neurotransmitters systems, including acetylcholine and
cannabinoids so as to point to future directions for expanding the identified targets for
organophosphate effects on brain development. It is important to note that the use of agents to
prevent the adverse effects of chlorpyrifos not only provides information about the mechanisms
underlying developmental disruption, but also points to the potential development of
mechanistically-based interventions to offset neuroteratogenicity.
METHODS
Adult Lytechinus variegatus sea urchins were obtained from the Duke University Marine
Laboratory (Beaufort, NC) and were transported to the University of North Carolina at Chapel
Hill, maintaining a temperature of 2–4° C. They were then kept in circulating and filtered
artificial sea water (ASW; 445 mM NaCl, 24.6 mM MgCl2, 18.1 mM MgSO4, 9.2 mM KCl,
2.36 mM NaHCO3, 11.5 mM CaCl2, pH 7.5) with their normal food (kelp) at 21° C.
Strongylocentrotus droebachiensis, Sphaerechinus granularis and Dendraster excentricus sea
urchins were collected using scuba and then used immediately for experiments or maintained
in natural sea water up to a salinity of 3.3% at the appropriate temperature for each species (8–
12.5° C for S. droebachiensis and D. excentricus; 21° C for S. granularis. The techniques for
maintenance of these species of adult sea urchins and for insemination and handling of embryos
and larvae in ASW have been described previously in detail, along with all the landmarks of
normal development [20]. The eggs or sperm were obtained by injecting the ripe animals with
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0.2–4 ml (depending on the size of the animals) of 0.55 M KCl; some animals were re-injected
after about 20 days for an additional harvest. The suspensions of unfertilized eggs (except for
D. excentricus) were passed through a nylon mesh for elimination of the jelly coat and
fertilization of the eggs was carried out using the combined sperm of 2–3 males for each female;
for D. excentricus, the jelly coat was removed by washing in acidified (pH 5) ASW prior to
filtration.
For the testing of neurochemicals, approximately 50–100 embryos or larvae were placed in
each 1 ml well of a multiwell cell culture plate. The substances were added at various stages
of development from the initial cleavage divisions, or more commonly at mid-blastula 2 or
early gastrula 1 stages [19,23] and were then present continuously thereafter. The effects on
embryonic and/or larval phenotypes were documented by digital photography using a Leitz
Orthoplan or Olympus Universal Research microscope. Imaging began at 2–4 hr after the start
of treatment, with image capture occurring at appropriate times to document treatment effects,
by an observer blinded to the treatments. Chlorpyrifos (Chem Service, West Chester PA) and
reserpine (Sigma Chemical Co., St. Louis MO) were tested as developmental disruptors, with
concentrations based on earlier studies showing teratogenic effects in the sea urchin by
chlorpyrifos [19,23], or depletion of monoamines and impaired growth in Tetrahymena for
reserpine [8]. The neurotransmitter analogs used for amelioration of the effects of chlorpyrifos
and reserpine were chosen on the basis of their actions on specific receptors and/or their
lipophilicity, as required to penetrate the hyaline barrier that impairs the entry of hydrophilic
substances into the embryo as well as the membrane barriers within the embryo [52]. For
serotonin, we used 5HT HCl (Sigma Chemical Co.), the hydrophilic derivative, N,N,N-
trimethyl 5HT (5HTQ, Sigma Chemical Co.) and the lipophilic congener, arachidonoyl
serotonin (AA-5HT, synthesized in the laboratory of Dr. V.V. Bezuglov); for dopamine, we
tested the lipophilic derivatives, arachidonoyl dopamine (AA-DA, Dr. Bezuglov) and
arachidonoyl tyramine (AA-TA, Dr. Bezuglov); for acetylcholine, we evaluated l-nicotine
bitartrate (Sigma Chemical Co.) and the lipophilic congener, arachidonoyl
dimethylaminoethanol (AA-DMAE, Dr. Bezuglov); and for cannabinoid systems, we utilized
arachidonoyl vanillylamine (AA-VAN, Dr. Bezuglov) and arachidonoyl ethylene glycol (AA-
EG, Dr. Bezuglov). Stock solutions of the hydrophilic agents (5HT, 5HTQ) were prepared in
distilled water, whereas the lipophilic agents were dissolved in methanol, ethanol or
dimethylsulfoxide [15,19,23,52], with the final vehicle concentration in the ASW medium
ranging from 0.1–0.2%. We chose a variety of vehicles so as to enable us to verify that none
of the vehicles had any direct actions by themselves, and to assure that the choice of vehicle
did not influence the outcome from chlorpyrifos or reserpine exposure or for any of the
amelioration treatments. The control groups for each study always contained the same vehicle
or mixture of vehicles and in no case did any of the control groups show differences in
development from each other or from the established morphological landmarks or temporal
relationships for normal sea urchin development [23].
Studies were conducted in all the sea urchin species, with similar results except where indicated.
We examined thousands of embryos from each batch of fertilized eggs from each individual
female. Because the same phenotype was seen for virtually all embryos at the doses tested, the
results are given as representative photomicrographs (magnification 100–200×) from two of
the species: S. granularis and S. droebachiensis. Within an experiment, each individual adult
female provided embryos for all treatment groups so that comparisons of treatment effects
could be made within the same cohort of embryos. Treatment effects were uniform across
cohorts of embryos from all the individuals. The total numbers of females used to obtain the
embryos were 25 for S. granularis, 23 for S. droebachiensis, 18 for L. variegatus and 9 for D.
excentricus. Given that the thousands of embryos in each treatment group had virtually identical
phenotypes and that malformed embryos were never seen in the control groups, statistical
analyses were restricted to simply assessing the proportions of wells showing malformations
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in the treated vs. control groups, regarding the embryos in a given well as a single sample.
Using Fisher’s Exact Test, all treatment effects described in the Results section were significant
at p < 0.0001.
RESULTS AND DISCUSSION
In our previous work with chlorpyrifos in the sea urchins, S. droebachiensis and S.
pupuratus embryos and larvae, we provided extensive documentation and images concerning
the critical periods of vulnerability and concentration-effect relationships for adverse effects
on development [19,23]. These included a scoring scale for the types of defects as well as
quantitative analyses across thousands of embryos but since the phenotypic outcomes for any
given treatment condition tend to be entirely uniform, the current results are presented as
representative photomicrographs. In the current work, we examined several other species and
found virtually identical effects of chlorpyrifos with the same threshold (2–5 μM) for all (data
not shown). Accordingly, only a few pictures for effects of chlorpyrifos alone will be shown
here to enable comparisons with reserpine and with therapeutic interventions. As discussed
below, we also found anomalies for reserpine that resembled those of chlorpyrifos in some but
not all developmental periods, and which responded similarly to many of the therapeutic agents.
Notably, we did find a species difference in the sensitivity to reserpine: the threshold
concentration for adverse effects in S. granularis (0.25–0.5 μM) was about ten-fold lower than
in the other species (2–4 μM).
Chlorpyrifos
Even at high concentrations, addition of chlorpyrifos during the first few cleavage divisions
has little or no effect on development up to the beginning of gastrulation [19,23], a result that
we replicated in the present study (Figure 1A). With treatment initiated later, at or just before
the mid-blastula 2 stage, chlorpyrifos elicited the same malformations we found earlier [19,
23], with all embryos displaying a uniform phenotype characterized by accumulation of
pigmented cells in the larval cavity (blastocoele) and their extrusion through the animal pole,
forming a “mushroom”-shaped larva (Figure 1B). Also like our previous results [19,23], we
again found the greatest sensitivity to chlorpyrifos with exposure commencing at the late
blastula stage (30 hr after fertilization), after which the sensitivity declines (data not shown).
Reserpine
In contrast to the limited effects of chlorpyrifos on early cleavage divisions, reserpine appeared
to inhibit or, at higher concentrations, completely block cell division, resulting in the formation
of abnormal blastulae (Figure 1A); the reserpine-exposed embryos extruded cells into the
perivitelline space (a lethal phenotype) and were incapable of further development. Despite
this difference in the response to early developmental exposure, when reserpine was introduced
at later stages of development we found reserpine-induced malformations similar to those seen
for chlorpyrifos [19,23], with the types of malformations shifting with stage of exposure in
parallel for both agents. With administration of reserpine during the mid-blastula 2 stage, we
found abnormal, pigmented cells, just as was true for chlorpyrifos, but with reserpine,
pigmented cells were found throughout the embryo (Figure 1B). Also, like chlorpyrifos,
reserpine elicited exogastrulation simultaneously with the appearance of pigmented cells.
When reserpine was given later, at the early gastrula 2 stage, we saw the same progression of
anomalies emerging by the pluteus stage, ranging from undeveloped arms at low
concentrations, to absent arms and eventual block of development at progressively higher
concentrations (Figure 2). Again, this mirrors the actions of chlorpyrifos and/or agents that
interfere with functioning of acetylcholine systems [19,23,52], raising the possibility of
convergent effects of different neurotransmitter systems on the same developmental outcomes;
we will see later on how this comes about.
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Amelioration by 5HT analogs
Our results showed that, although chlorpyrifos and reserpine differ in their actions at initial
stages of development, with treatment begun at or after the mid-blastula stage, they eventually
converge on a common set of anomalies. The initial cleavage divisions of the sea urchin embryo
are controlled in part by 5HT mechanisms [12,20,60], so the fact that reserpine, but not
chlorpyrifos, interferes with the divisions suggests that chlorpyrifos does not have adverse
effects on 5HT function at this earliest stage, or at least not to the extent that reserpine does.
In the developing mammalian brain, reserpine also interferes with neuronal mitosis but this
effect occurs even in brain regions very sparse in 5HT projections [43,49] and can also be
demonstrated in regenerating liver and tumors [25,40], raising the possibility that the actions
of reserpine on mitotic events are separable from its effects on 5HT and/or other monoamines.
Accordingly, to determine if the outcomes seen here in the sea urchin model are indeed related
to 5HT depletion, we examined whether they could be prevented by coadministration of 5HT
analogs (Figure 3). The lipophilic 5HT analog, AA-5HT, provided complete protection from
the effects of reserpine introduced during the early cleavage divisions, whereas the less-
lipophilic native neurotransmitter, 5HT provided only partial protection. The hydrophilic
analog, 5HTQ, was not effective. Accordingly, the damage resulting from reserpine exposure
at the initiation of embryonic development is most likely related to its interference with 5HT
mechanisms, and it is then equally clear that chlorpyrifos does not share this particular effect.
In turn, this implies that the early stages of effects of chlorpyrifos on 5HT systems in the
developing mammalian brain are probably a consequence of disruption of neurodevelopmental
mechanisms, rather than by interference with 5HT as a trophic factor that produces the
disruption. As shall be seen later, however, this is not necessarily the case throughout
development. Finally, the fact that 5HT itself has partial activity effectively rules out the
potential artifact that the AA-5HT analog might work because of the arachidonoyl moiety
acting as part of the arachidonic acid signaling cascade. In fact, arachidonic acid alone has no
such effects (data not shown).
Given the convergence of effects of chlorpyrifos and reserpine on later-stage defects, our next
objective was to determine the extent to which 5HT mechanisms participate in these, again
using the strategy of prevention by AA-5HT. First, we conducted an extensive bidirectional
concentration-response study, varying both the concentrations of reserpine and AA-5HT
(Figure 4). By itself, reserpine at concentrations ranging from 2–16 μM produced profound
disruption of development, with the characteristic appearance of pigmented cells, mushroom-
shaped larvae, and exogastrulation. As little as 10 μM AA-5HT provided nearly complete
protection against the lowest reserpine concentration, whereas progressively high
concentrations of AA-5HT were required as the reserpine exposure was increased.
Nevertheless, even at the highest reserpine concentration, 40 μM AA-5HT was effective.
Accordingly, we used this concentration in a parallel test of protection against chlorpyrifos and
reserpine and found clear-cut protection against either agent (Figure 5); again, the impermeant
analog, 5HTQ was ineffective.
This finding indicates that, when the adverse effects of chlorpyrifos emerge, they too can be
reversed by activating 5HT systems, just as is the case for the monoamine depleter, reserpine.
Accordingly, there are two distinct phases of developmental sensitivity to chlorpyrifos: little
or no effect early in development (initial cleavage divisions) but later emergence of profound
effects at the mid-blastula stage. This has its parallel in the effects of chlorpyrifos on the
immature mammalian brain, where greatest sensitivity is noted at stages of neuronal
development just at the point of differentiation into specific neurotransmitter phenotypes [39,
63,65,69]. Again, this includes prominent effects on 5HT systems in the mammalian brain
[3,56,69,73]. However, the reversal of adverse effects by AA-5HT in the sea urchin model
suggests that, during this phase, alterations in 5HT function by chlorpyrifos do affect the trophic
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functions of this neurotransmitter, since this hydrophobic 5HT analog prevented the adverse
morphological outcomes. In that sense, 5HT systems and the downstream events they mediate
are a target for disruption by chlorpyrifos exposure, and simultaneously a participating
mechanism by which subsequent disruption of other systems occurs.
Amelioration by analogs of other neurotransmitters
The protection of the effects of both chlorpyrifos and reserpine by 5HT analogs findings
presents us with a conundrum. Reserpine depletes other monoamines besides 5HT [61], and
chlorpyrifos is known to act on a variety of neurotransmitters besides 5HT, including the other
monoamines and of course, acetylcholine [62,63,65]. Why, then, should simply replacing the
function of 5HT with 5HT itself or AA-5HT reverse the adverse actions of either of these
agents? To answer this question, we next pursued a series of parallel studies with analogs of
dopamine, acetylcholine and cannabinoids, to see if agents targeting the receptors for these
systems would exert protective effects similar to that of AA-5HT (Figure 5). The membrane-
permeant dopamine congener, AA-DA provided some protection against reserpine as well as
chlorpyrifos, albeit less so for the latter. Surprisingly, however, a similar catecholamine analog
based on tyramine (which lacks the meta-hydroxyl group present in dopamine), AA-TA,
proved to be extremely effective against the adverse effects of reserpine but not chlorpyrifos.
We reinforced this unexpected finding by conducting a dose-response study and found
demonstrable protection from reserpine with as little as 2.5 μM AA-TA (Figure 6, top panel).
There are two questions raised by these results. First, why is AA-TA much more effective than
AA-DA, and second, why can AA-TA reverse the effects of reserpine but not chlorpyrifos?
For the first question, there may be significant pharmacokinetic, metabolic or
pharmacodynamic differences between AA-DA and AA-TA. The additional hydroxyl group
on dopamine increases its hydrophilicity, which would render it less permeant than the
corresponding tyramine analog; similarly, the native compounds have differing affinities for
monoamine oxidase, so that AA-DA could be metabolically inactivated to a greater extent than
AA-TA. However, given the large disparity in protective actions between AA-DA and AA-
TA, a third alternative seems the most likely: pharmacodynamic differences in the mechanisms
of action of the two agents. One possibility is that the attachment of the arachidonoyl moiety
to dopamine and tyramine could change their relative affinities for dopamine receptors,
although it is difficult to conceive why that should create a preferential effect for AA-TA. A
second possibility seems more likely: the existence of neurotransmitter receptors for tyramine
or its β-hydroxylated downstream metabolic product, octopamine. Receptors for these amines
are notable in lower organisms, and it is now clear that, rather than just representing “trace”
amines in the mammalian brain, receptors for tyramine and octopamine are present and active
there, too [11]. Our findings for AA-TA and AA-DA thus point to a potential developmental
role for these simpler amines and their receptors, an area deserving of future investigation.
The second issue, the ability of AA-TA to provide protection from reserpine, but not
chlorpyrifos, points toward a further important difference between the two developmental
disruptors. Whereas reserpine exerts its effects almost exclusively against monoamine systems,
chlorpyrifos affects diverse neurotransmitter systems over and above 5HT or dopamine, most
notably acetylcholine [62,63,65]. In our earlier work, we showed that AA-DMAE, which binds
to nicotinic acetylcholine receptors and, dependent upon concentration, produces both
stimulation and inhibition/desensitization (as do all nicotinic receptor agonists), can protect
sea urchin embryos from the adverse effects of chlorpyrifos [19,23]. With the additional species
in the current study, we repeated that finding: 40 μM AA-DMAE prevented the effects of
chlorpyrifos added at the mid-blastula stage and furthermore, also protected them from
reserpine (Figure 5). The latter effect was entirely surprising, given the specificity of reserpine
for monoamine systems, and accordingly, we again pursued this more extensively through a
dose-response study (Figure 6, bottom panel), where a concentration of 20 μM AA-DMAE
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provided complete protection against reserpine. We also evaluated nicotine itself, which proved
to be partially effective against reserpine, albeit less so than AA-DMAE, and relatively
ineffective against chlorpyrifos (Figure 5). In studies with developing neuronotypic cells in
culture, nicotine does provide partial protection against the adverse effects of chlorpyrifos on
differentiation and oxidative stress [54,55], so the relative insensitivity here may again reside
in pharmacokinetic differences such as metabolic or oxidative degradation of nicotine.
Alternatively, the concentration of nicotine chosen here may not reside on the appropriate part
of its biphasic concentration-response curve to achieve the comparable balance of receptor
stimulation and inhibition/desensitization. Again, further studies are warranted to examine this
possibility.
In a final set of experiments, we explored whether analogs of cannabinoid receptor agonists
could also protect sea urchin embryos from the adverse effects of chlorpyrifos or reserpine
given at the mid-blastula stage (Figure 5). Here, we found that AA-VAN provided effective
protection from the actions of either chlorpyrifos or reserpine, and another analog, AA-EG was
somewhat effective. Recent studies show that cannabinoids can partially protect adult rats from
acute organophosphate intoxication, with the presumed mechanism of reducing acetylcholine
release so as to lessen the consequences of cholinesterase inhibition [48]. That mechanism
seems highly unlikely here, since AA-VAN worked against both chlorpyrifos and reserpine,
and further interference with neurotransmitter release or actions would be expected to worsen
the outcomes in the sea urchin embryos. Instead, all our results point in a different direction.
We found that, regardless of originating mechanism of action, the effects of chlorpyrifos or
reserpine could actually be prevented by a variety of agents acting on different transmitter
systems: AA-5HT, AA-TA, AA-DMAE, AA-VAN. So, for reserpine, despite the fact that it
acts by depleting monoamines, agents like AA-DMAE, nicotine and AA-VAN provided
protection. For chlorpyrifos, although it acts on a wide variety of neurotransmitter systems,
agents working through any one of the targeted systems can similarly reverse the adverse
effects, at least in part. It is thus apparent that all these various activities converge on a shared
set of downstream signaling elements that are essential for proper morphological assembly of
the embryo. Indeed, for chlorpyrifos, we already know that actions exerted on these common
signaling pathways, most prominently adenylyl cyclase/protein kinase A and protein kinase
C, provide both a mechanism for disruption of development and a therapeutic target for
preventing those effects [80,81]. In the current study, then, profound activation of any one of
the inputs to these pathways may serve to offset the adverse effects mediated by other, parallel
inputs to those pathways or by disruption of multiple inputs. At the same time, this provides
information that may be essential to designing ameliorative therapies for mammalian exposure
to organophosphates or other neurodevelopmental toxicants, i.e. regardless of underlying
mechanism, certain neuroactive agents that share common signaling cascades, may prove to
be effective against a wide variety of disruptors.
Conclusion
There are two essential findings from the current study. First, the adverse effects of chlorpyrifos
on 5HT systems in the immature mammalian brain, and similar effects reported for other
organophosphates [53,62,63,65–67,69,71,73], likely represent a downstream target of the
primary disruption of neural cell differentiation by these agents; but at the same time, because
of the neurotrophic role of 5HT, the effects of organophosphates on this transmitter system
provide a mechanism by which more widespread developmental perturbations come about.
Second, the fact that the effects of agents with disparate originating mechanisms of action can
be offset by administering single neuroactive congeners that work on specific neurotransmitter
systems points to therapeutic approaches that may be applicable to a wider variety of
neurodevelopmental insults. We are currently exploring this possibility in a variety of test
systems.
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Effects of chlorpyrifos or reserpine on the early development of S. droebachiensis: (A)
exposures begun at the 2–4 cell stage (3.7 hr after fertilization) and images obtained at 22.5 hr
after fertilization; (B) exposures begun at the mid-blastula stage (22.5 hr after fertilization) and
images obtained at 34.7 hr after fertilization.
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Effects of reserpine on the development of S. granularis larvae, given at the early gastrula 2
stage (15.75 hr after fertilization); images were obtained at the mid-pluteus 1 stage (45 hr after
fertilization). Note the dose-dependent progression of malformations: (0.5 μM) almost normal
development, (1 μM) underdeveloped first pair of arms and absent second pair of arms, (2
μM) no arms and hyperproduced chromatophores, (4 μM) block of development before the
end of gastrulation and accumulation of pigmented cells in the blastocoele.
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Protective actions of 5HT derivatives in S. granularis embryos. Reserpine was introduced
simultaneously with the 5HT analogs at the two-cell stage (2 hr post-fertilization) and images
obtained at the early prism stage (26.1 hr post-fertilization). Reserpine alone results in death
of the embryos, whereas AA-5HT provides full protection for reserpine. 5HT and 5HTQ, which
are progressively less permeable, provide correspondingly less protection.
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Protective actions of AA-5HT against the effects of reserpine in S. granularis embryos.
Reserpine and AA- 5HT were introduced simultaneously at the mid-blastula stage (13.75 hr
post-fertilization) and images obtained at the late gastrula stage (24.1 hr post-fertilization). The
dose-dependent adverse effects of reserpine and their prevention by AA-5HT are obvious.
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Protection of S. granularis larvae against chlorpyrifos or reserpine. Agents were given at the
mid-blastula 2 stage (15.75 hr after fertilization) and images were obtained at 23.1 hr after
fertilization.
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Dose-dependent protection of S. granularis larvae against reserpine by AA-TA (top row) and
AA-DMAE (bottom row). Agents were given at the mid-blastula 2 stage (13.75 hr after
fertilization) and images were obtained at 26.5 hr (top) or 24.2 hr (bottom) after fertilization.
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